Get Our Top Trade Ideas Delivered Daily - 65% Off Now

+ New Watchlist

Benzinga Research

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Vertex Pharmaceuticals

VRTXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$475.77

1.610.34%

After Hours: 9:27 AM EDT

15 minutes delayed

Vertex Pharmaceuticals (VRTX) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest news for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock

Vertex Pharmaceuticals Stock (NASDAQ: VRTX)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, September 19, 2024

Demystifying Vertex Pharmaceuticals: Insights From 16 Analyst Reviews
Benzinga Insights
RBC Capital Reiterates Sector Perform on Vert...
Benzinga Newsdesk

Wednesday, September 18, 2024

Looking Into Vertex Pharmaceuticals's Recent Short Interest
Benzinga Insights

Friday, September 06, 2024

Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years
Benzinga Insights

Thursday, August 29, 2024

Vertex Pharmaceuticals's Options Frenzy: What You Need to Know
Benzinga Insights
Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics
Avi Kapoor

Tuesday, August 27, 2024

Looking Into Vertex Pharmaceuticals's Recent Short Interest
Benzinga Insights

Friday, August 23, 2024

Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals
Benzinga Insights

Wednesday, August 21, 2024

If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,900 Today
Benzinga Insights

Tuesday, August 20, 2024

NSA Code Breaker Jim Simons' Hedge Fund Renaissance Technologies — Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings
Kaustubh Bagalkote

Thursday, August 15, 2024

10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights

Friday, August 09, 2024

Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals
Benzinga Insights

Thursday, August 08, 2024

Editas Q2 Earnings & Revenues Miss Estimates, Stock Down
Zacks
Reported Earlier, Vertex Secures NHS England ...
Benzinga Newsdesk

Monday, August 05, 2024

HC Wainwright & Co. Maintains Buy on Vertex P...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on Vertex Ph...
Benzinga Newsdesk
JP Morgan Maintains Overweight on Vertex Phar...
Benzinga Newsdesk
Truist Securities Reiterates Buy on Vertex Ph...
Benzinga Newsdesk
Vertex Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Barclays Downgrades Vertex Pharmaceuticals to...
Benzinga Newsdesk

Friday, August 02, 2024

Guggenheim Maintains Buy on Vertex Pharmaceut...
Benzinga Newsdesk
Magnificent 7 Lose Over $300B As Volatility Index Surges, Traders Question Fed's Timing: What's Driving Markets Friday?
Piero Cingari
Vertex Pharmaceuticals Lifts Annual Guidance, Positive Growth For Its Cystic Fibrosis Franchise And Pain Management Pipeline
Vandana Singh
Cantor Fitzgerald Reiterates Overweight on Ve...
Benzinga Newsdesk
Piper Sandler Maintains Overweight on Vertex ...
Benzinga Newsdesk

Thursday, August 01, 2024

Vertex Pharmaceuticals Raises FY24 Revenue Gu...
Benzinga Newsdesk
Vertex Pharmaceuticals Q2 Adj $(12.83) Misses...
Benzinga Newsdesk
US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday?
Piero Cingari
Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November
Shanthi Rexaline

Wednesday, July 31, 2024

Should You Invest in the iShares Biotechnology ETF?
Zacks
14 Analysts Assess Vertex Pharmaceuticals: What You Need To Know
Benzinga Insights
Canaccord Genuity Maintains Sell on Vertex Ph...
Benzinga Newsdesk

Tuesday, July 30, 2024

Vertex Announces FDA AcceptanceOf New Drug Ap...
Benzinga Newsdesk

Monday, July 29, 2024

Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
Shanthi Rexaline

Friday, July 26, 2024

Needham Reiterates Hold on Vertex Pharmaceuti...
Benzinga Newsdesk

Tuesday, July 23, 2024

TD Cowen Maintains Buy on Vertex Pharmaceutic...
Benzinga Newsdesk
Here's How Much $100 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth Today
Benzinga Insights

Monday, July 22, 2024

Cantor Fitzgerald Maintains Overweight on Ver...
Benzinga Newsdesk

Friday, July 19, 2024

HC Wainwright & Co. Maintains Buy on Vertex P...
Benzinga Newsdesk

Tuesday, July 16, 2024

Genomics Extends And Expansion Drug Discovery...
Benzinga Newsdesk

Monday, July 15, 2024

Vertex Seeks Court Confirmation That Financia...
Benzinga Newsdesk
Vertex Pharmaceuticals Sues U.S. Department O...
Benzinga Newsdesk
Health Canada Grants Marketing Authorization ...
Benzinga Newsdesk

Thursday, July 11, 2024

Forecasting The Future: 13 Analyst Projections For Vertex Pharmaceuticals
Benzinga Insights
Morgan Stanley Maintains Equal-Weight on Vert...
Benzinga Newsdesk

Wednesday, July 10, 2024

Check Out What Whales Are Doing With VRTX
Benzinga Insights

Tuesday, July 02, 2024

Vertex Pharmaceuticals Announces FDA Acceptan...
Benzinga Newsdesk

Monday, July 01, 2024

$1000 Invested In This Stock 15 Years Ago Would Be Worth $14,000 Today
Benzinga Insights

Thursday, June 27, 2024

This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Avi Kapoor
Redburn Atlantic Initiates Coverage On Vertex...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved